"China Medical University Hospital" is one of the Ever Supreme collaborating medical institutes. CMUH was approved by the Taiwan FDA for the "Stage IV Solid Cancer" patients by autologous immune cell therapy (DC-CIK) on May 1, 2020. Patients who meet the criteria and admitted in the given treatment including the following indications: solid cancer Stage IV with liver cancer, colorectal cancer, breast cancer, and lung cancer. More applications under RGSCTT is on its way to approval, and we expected that more patients will be benefited, and a new scope of cell therapy is available, which also represents Taiwan is ready for the new era of cell therapy as well.
.jpg)